Moreover, another independent study led by Ferna'ndez-Hernando from Yale reported that lack of hematopoietic cell-derived ANGPTL4, one of the inhibitors of LPL, also promoted atherosclerosis by regulating monocyte expansion in LDLR−/− mice (19). Here, ANGPTL4 is linked to atherosclerosis.